Getting Worse Not Better: UK Report On Access To Cancer Drugs
Executive Summary
A UK report on patient access to cancer drugs suggests that the European Medicines Agency could learn from the US Food and Drug Administration and best practice elsewhere in the world when it comes to taking a faster, more flexible approach to assessing evidence.